RB in breast cancer: differential effects in estrogen receptor-positive and estrogen receptor-negative disease.
about
Palbociclib: A breakthrough in breast carcinoma in women.Palbociclib: an evidence-based review of its potential in the treatment of breast cancerRas/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.Overcoming Endocrine Resistance in Hormone-Receptor Positive Advanced Breast Cancer-The Emerging Role of CDK4/6 InhibitorsEctopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine
P2860
RB in breast cancer: differential effects in estrogen receptor-positive and estrogen receptor-negative disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
RB in breast cancer: different ...... gen receptor-negative disease.
@en
RB in breast cancer: different ...... gen receptor-negative disease.
@nl
type
label
RB in breast cancer: different ...... gen receptor-negative disease.
@en
RB in breast cancer: different ...... gen receptor-negative disease.
@nl
prefLabel
RB in breast cancer: different ...... gen receptor-negative disease.
@en
RB in breast cancer: different ...... gen receptor-negative disease.
@nl
P2860
P356
P1433
P1476
RB in breast cancer: different ...... gen receptor-negative disease.
@en
P2093
Elizabeth A Musgrove
Robert L Sutherland
P2860
P356
10.4161/CC.9.23.13889
P577
2010-12-01T00:00:00Z